Supervisory Board


Gerald Möller, PhD, Chairman, former CEO of Boehringer Mannheim Group, and Member of the Executive Committee of Hoffmann La Roche. Dr Moeller currently holds various Non-Executive Board memberships in healthcare companies in the US, UK and Germany and is Investment Advisor of HBM Partners. He is also Chairman of FIND, a diagnostic initiative of the Bill & Melinda Gates Foundation.

Erich Platzer, M.D., B.Sc., Investment Advisor of HBM Partners and former Head of the Roche Oncology Strategic Marketing Department. Dr. Platzer is a board-certified haematologist and medical oncologist.

Prof Magnus von Knebel Döberitz, MD, is scientific founder of mtm laboratories and Professor in the Department of Applied Tumor Biology at the University of Heidelberg. (Institute of Pathology)

Rainer Strohmenger, M.D., M.Sc., Partner of Wellington Partners (Munich). Dr. Strohmenger focuses on investments in the life sciences industry and co-managed and successfully exited the firm's investments in Actelion, Grandis, Perfect Vision and Wavelight.

Berthold Hackl, MBA, is Managing Partner of Heidelberg Innovation. He currently holds supervisory board seats in Arthro Kinetics, Digilab, invendo medical and mtm laboratories

Werner Schäfer, Ph.D., Consultant to the biotech and diagnostic industry, former member of the Management Board of Roche Diagnostics GmbH and Director of Area Operations and Scientific Development at Abbott GmbH Diagnostics.



Products


News